Partnership will optimize manufacturing of extracellular vesicles (EVs) using scalable and continuous bioprocessing technologies to propel the commercialization of regenerative therapies at affordable costs.

The two companies announce a worldwide strategic partnership to develop and optimize platform processes using best-in-class technologies for the production of custom viral vectors.

The scale-X carbo will be featured at the Dublin facility for biopharma industry researchers and personnel to gain hands-on experience with this and other leading next-generation, enabling biomanufacturing technologies

In his new role, Mathias will take the company through the next stage of strategic development and growth

Exyte and Univercells Technologies are announcing a global partnership for optimized construction of modular standardized and flexible GMP manufacturing facilities for vaccines.

The investment will be deployed in a newly created subsidiary of Univercells focused on accelerating the industrialization and commercialization of Univercells’ manufacturing technologies

Univercells and consortium partner Batavia Biosciences have been awarded a $4 million grant extension by the Bill & Melinda Gates Foundation to scale up their low-cost polio vaccine manufacturing technology.

Univercells Receives $12 Million Grant to Develop Breakthrough Vaccine Manufacturing Platform